---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-084412"
form_type: "8-K"
ticker: "ALUR"
cik: "0001964979"
company_name: "ALLURION TECHNOLOGIES, INC."
filed_at: "2026-03-02T23:59:59+00:00"
generated_at: "2026-05-15T22:49:38.244716+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Allurion receives NYSE delisting notice for non-compliance with equity/market cap standard; intends to appeal

## Summary
- NYSE notified Allurion it fails Section 802.01B: requires ≥$50M stockholders' equity or ≥$50M market cap on 30-day average.
- Company intends to appeal; shares expected to continue trading on NYSE during the appeal process.
- Recent FDA approval on Feb 20, 2026 cited as catalyst for regaining compliance or relisting on another exchange.
- Also pursuing debt-for-preferred exchange with largest creditor and completed warrant inducement on Feb 24, 2026.
- No guarantee of success; risk of delisting and negative impact on liquidity and capital access if appeal fails.

## SEC filing metadata
- accession: 0001193125-26-084412
- form_type: 8-K
- ticker: ALUR
- cik: 0001964979
- company_name: ALLURION TECHNOLOGIES, INC.
- filed_at: 2026-03-02T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 3.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1964979/000119312526084412/0001193125-26-084412-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1964979/000119312526084412/d39723d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-084412
- JSON: https://secwatch.observer/filing/0001193125-26-084412.json
- Plain text: https://secwatch.observer/filing/0001193125-26-084412.txt

## Source-grounded claims
- claim_id: bd08961cf9d9a95f382bb9d46ca164a00332e87f
  claim: ALLURION TECHNOLOGIES, INC. received a nyse delisting notice notice regarding other (rules 802.01B).
  evidence_excerpt: March 2, 2026, Allurion Technologies, Inc., a Delaware corporation (the “Company”) announced that it received a letter (the “Delisting Notice”) from the staff of the New York Stock Exchange (the “Exchange” or “NYSE”) indicating that the Company does not meet certain of the Exchange’s continued listing standards as set forth in Section 802.01B of the NYSE Listed Company Manual that require listed companies to maintain either (i) at least $50 million in stockholders’ equity or (ii) at least $50 million in total market capitalization on a 30-trading day average basis and that the Exchange will be
  evidence_url: https://www.sec.gov/Archives/edgar/data/1964979/000119312526084412/0001193125-26-084412-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.